Abstract

Streptomycin consists of three components, which are linked together by glycoside bonds, and it belongs to the group of the aminoglycoside antibiotics. Streptomycin is naturally produced by actinobacterium Streptomyces griseus. Therapeutically it is used in the case of streptococcal and enterococcal enteritis. Because of its side effects it is rarely used in human treatment, but has an application in the veterinary area. After the treatment of mastitis in breeding animals, increased values of streptomycin were also recorded in liver, kidney, muscle and milk. Presence of Streptomycins in milk has hygienic and industrial implications. Concerning the industrial aspect the Streptomycin residues are inhibitors for proliferation of the lactic microflora. In terms of hygiene, streptomycin can induce the antibiotic resistance phenomenon

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call